This content is machine translated News on melanoma therapy at ASCO 2014 How do immunotherapies work in combination and in the adjuvant setting? In the course of this year’s ASCO congress in Chicago at the beginning of June, new results of the phase Ib study on the combination of PD1 and CTLA4 inhibition…
